Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-alpha-methylspermidine + O2 + H2O
?
-
PAO supplemented with benzaldehyde predominantly catalyzes the cleavage of (R)-isomer of alpha-methylspermidine, whereas in the presence of pyridoxal the (S)-alpha-methylspermidine is preferred
-
-
?
(S)-alpha-methylspermidine + O2 + H2O
?
-
PAO supplemented with benzaldehyde predominantly catalyzes the cleavage of (R)-isomer of alpha-methylspermidine, whereas in the presence of pyridoxal the (S)-alpha-methylspermidine is preferred
-
-
?
(S)-N1-(2-methyl-1-butyl)-N11-ethyl-4,8-diazaundecane-1,11-diamine + O2 + H2O
?
-
-
-
?
1-amino-8-acetamido-5-azanonane + O2 + H2O
?
-
less preferred substrate
-
-
?
3-[4-(3-aminopropoxy)butoxy]-N-benzylpropan-1-amine + O2 + H2O
?
-
-
-
?
alpha-methylspermidine + O2 + H2O
?
-
weak oxidation in presence of benzaldehyde, no oxidation without benzaldehyde
-
-
?
alpha-methylspermine + O2 + H2O
?
-
oxidation in presence of benzaldehyde, no oxidation without benzaldehyde
-
-
?
alpha-methylspermine + O2 + H2O
spermidine + alpha-methylspermidine + ?
-
-
-
-
?
bis-alpha,alpha'-methylspermine + O2 + H2O
alpha-methylspermidine + ?
-
-
-
-
?
N,N'-bis-(3-benzylaminopropyl)butane-1,4-diamine + O2 + H2O
N1-(3-benzylaminopropyl)butane-1,4-diamine + H2O2 + ?
-
-
main product
-
?
N,N'-bis-(3-benzylaminopropyl)butane-1,4-diamine + O2 + H2O
N1-(3-benzylaminopropyl)butane-1,4-diamine + N-(3-aminopropyl)-N'-(3-Benzylaminopropyl)butane-1,4-diamine + H2O2
-
-
-
-
?
N,N'-bis-(3-ethylaminopropyl)butane-1,4-diamine + O2 + H2O
N1-(3-ethylaminopropyl)butane-1,4-diamine + H2O2 + ?
-
minor N4-endo cleavage pathways resulting in formation of N1-ethylpropane-1,3-diamine
-
-
?
N-(3-benzylaminopropyl)-N'-(3-ethylaminopropyl)butane-1,4-diamine + O2 + H2O
N1-(3-ethylaminopropyl)butane-1,4-diamine + H2O2 + ?
-
-
-
-
?
N-[(2R)-4-[(4-aminobutyl)amino]butan-2-yl]pyridine-4-carboxamide + O2 + H2O
putrescine + (3R)-3-[(pyridin-4-yl)amino]butanal + H2O2
-
-
-
?
N-[(2S)-4-[(4-aminobutyl)amino]butan-2-yl]pyridine-4-carboxamide + O2 + H2O
putrescine + (3S)-3-[(pyridin-4-yl)amino]butanal + H2O2
-
-
-
?
N1,N11-bis(ethyl)-norspermine + O2 + H2O
?
-
-
-
?
N1,N11-diacetylnorspermine + O2 + H2O
?
-
-
-
-
?
N1,N11-didansylnorspermine + O2 + H2O
1-dansylnorspermidine + 1-dansylamido-3-propanal + H2O2
N1,N11-didansylnorspermine + O2 + H2O
? + H2O2
-
-
-
-
?
N1,N11-diethylnorspermine + O2 + H2O
?
-
-
-
?
N1,N12-bis(ethyl)-spermine + O2 + H2O
?
-
-
-
?
N1,N12-bisethylspermine + H2O
?
mechanistic studies
-
-
?
N1,N12-diacetylspermine + O2 + H2O
?
N1,N12-diacetylspermine + O2 + H2O
N1-acetylspermidine + 3-acetamidopropanal + H2O2
N1,N12-diethylspermine + O2 + H2O
?
-
-
-
?
N1,N14-diethylhomospermine + O2 + H2O
?
-
-
-
?
N1-(3-benzylaminopropyl)butane-1,4-diamine + O2 + H2O
spermidine + H2O2 + benzylalcohol
-
-
-
-
?
N1-(3-[[(thiophen-2-yl)methyl]amino]propyl)octane-1,8-diamine + O2 + H2O
octane-1,8-diamine + N1-[(thiophen-2-yl)methyl]propanal + H2O2
-
-
-
?
N1-acetyl-2-methylspermidine + O2 + H2O
putrescine + N-(2-methyl-3-oxopropyl)acetamide + H2O2
-
-
-
?
N1-acetyl-8-methylspermidine + O2 + H2O
pentane-1,4-diamine + 3-acetamidopropanal + H2O2
-
-
-
?
N1-acetylspermidine + O2 + H2O
?
N1-acetylspermidine + O2 + H2O
putrescine + 3-acetamidopropanal
-
-
-
?
N1-acetylspermidine + O2 + H2O
putrescine + 3-acetamidopropanal + H2O2
N1-acetylspermidine + O2 + H2O
putrescine + 3-acetaminopropanal + H2O2
-
-
-
?
N1-acetylspermine + O2 + H2O
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
N1-acetylspermine + O2 + H2O
spermidine + 3-acetaminopropanal + H2O2
-
-
-
?
N1-benzoyl-(R)-alpha-methylspermidine + O2 + H2O
putrescine + N-[(2R)-4-oxobutan-2-yl]benzamide + H2O2
-
-
-
?
N1-benzoyl-(S)-alpha-methylspermidine + O2 + H2O
putrescine + N-[(2S)-4-oxobutan-2-yl]benzamide + H2O2
-
-
-
?
N1-benzyl-propane-1,3-diamine + O2 + H2O
propane-1,3-diamine + H2O2 + benzylalcohol
-
-
-
-
?
N1-benzyldodecane-1,12-diamine + O2 + H2O
dodecane-1,12-diamine + N1-benzylpropanal + H2O2
-
-
-
?
N1-benzylspermine + O2 + H2O
spermidine + 3-(benzylamino)propanal + H2O2
-
-
-
?
N1-cyclopropylmethyl-N11-ethylnorspermine + O2 + H2O
?
-
-
-
-
?
N1-ethyl-N11-(cycloheptyl)methyl-4,8-diazaundecane-1,11-diamine + O2 + H2O
?
-
-
-
?
N1-ethyl-N11-(cyclopropyl)methyl-4,8-diazaundecane + O2 + H2O
?
-
-
-
?
N1-phenyl-(R)-alpha-methylspermidine + O2 + H2O
putrescine + (3R)-3-anilinobutanal + H2O2
-
-
-
?
N1-phenyl-(S)-alpha-methylspermidine + O2 + H2O
putrescine + (3S)-3-anilinobutanal + H2O2
-
-
-
?
N1-[(naphthalen-2-yl)methyl]spermine + O2 + H2O
spermidine + N1-[(naphthalen-2-yl)methyl]propanal + H2O2
-
-
-
?
N1-[(pyridin-2-yl)methyl]spermine + O2 + H2O
spermidine + N1-[(pyridin-2-yl)methyl]propanal + H2O2
-
-
-
?
N1-[(thiophen-2-yl)methyl]dodecane-1,12-diamine + O2 + H2O
?
-
-
-
?
N1-[(thiophen-2-yl)methyl]spermine + O2 + H2O
spermidine + N1-[(thiophen-2-yl)methyl]propanal + H2O2
-
-
-
?
spermine + O2 + H2O
spermidine + 3-aminopropanal + H2O2
additional information
?
-
N1,N11-didansylnorspermine + O2 + H2O

1-dansylnorspermidine + 1-dansylamido-3-propanal + H2O2
-
-
-
-
?
N1,N11-didansylnorspermine + O2 + H2O
1-dansylnorspermidine + 1-dansylamido-3-propanal + H2O2
-
-
-
-
?
N1,N12-diacetylspermine + O2 + H2O

?
-
-
-
-
?
N1,N12-diacetylspermine + O2 + H2O
?
-
-
-
?
N1,N12-diacetylspermine + O2 + H2O
?
-
-
-
-
?
N1,N12-diacetylspermine + O2 + H2O

N1-acetylspermidine + 3-acetamidopropanal + H2O2
-
-
-
-
?
N1,N12-diacetylspermine + O2 + H2O
N1-acetylspermidine + 3-acetamidopropanal + H2O2
N1-acetylspermine is first liberated as a product and then oxidized further to putrescine
-
-
?
N1-acetylspermidine + O2 + H2O

?
-
-
-
-
?
N1-acetylspermidine + O2 + H2O
?
-
-
-
?
N1-acetylspermidine + O2 + H2O
?
-
-
-
-
?
N1-acetylspermidine + O2 + H2O
?
-
strongly preferred substrat, hPAO
-
-
?
N1-acetylspermidine + O2 + H2O
?
-
-
-
?
N1-acetylspermidine + O2 + H2O

putrescine + 3-acetamidopropanal + H2O2
-
-
-
-
?
N1-acetylspermidine + O2 + H2O
putrescine + 3-acetamidopropanal + H2O2
-
-
-
?
N1-acetylspermidine + O2 + H2O
putrescine + 3-acetamidopropanal + H2O2
-
the enzyme is involved in polyamine catabolism. The enzyme is a constitutively expressed enzyme that catalyzes the oxidative cleavage of N1-acetylpolyamines to yield a less basic polyamine, 3-acetylamidopropanal, and hydrogen peroxide
-
-
?
N1-acetylspermidine + O2 + H2O
putrescine + 3-acetamidopropanal + H2O2
oxidized at the carbon on the exo-side of the N4-nitrogen
-
-
?
N1-acetylspermine + O2 + H2O

?
-
-
-
-
?
N1-acetylspermine + O2 + H2O
?
-
-
-
?
N1-acetylspermine + O2 + H2O
?
-
-
-
-
?
N1-acetylspermine + O2 + H2O
?
-
-
-
?
N1-acetylspermine + O2 + H2O

spermidine + 3-acetamidopropanal + H2O2
-
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
at pH 6.5, substrate preference is in the following decreasing order: thermospermine, N1-acetylspermine, norspermine, spermine, spermidine. Spermidine is catabolized at a very low rate. At pH 7.5, substrate preference is in the following decreasing order: spermine, norspermine, N1-acetylspermine, thermospermine, spermidine. Spermidine is catalyzed at a very low rate
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
-
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
-
-
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
PAO preferentially oxidizes acetylspermine or acetylspermidine over spermine
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
-
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
oxidized at the carbon on the exo-side of the N4-nitrogen
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
-
-
-
?
N1-acetylspermine + O2 + H2O
spermidine + 3-acetamidopropanal + H2O2
at pH 8.0, the substrate preference in decreasing order is as follows: spermine/thermospermine, N1-acetylspermine, norspermine, spermidine. At pH 7.0, the substrate preference in decreasing order is as follows: thermospermine, norspermine, spermine, N1-acetylspermine, spermidine
-
-
?
spermidine + O2 + H2O

?
-
no activity in absence of aldehydes, weak activity in presence of aldehydes
-
-
?
spermidine + O2 + H2O
?
-
weak oxidation in presence of benzaldehyde, no oxidation without benzaldehyde
-
-
?
spermine + O2 + H2O

?
weak activity
-
-
?
spermine + O2 + H2O
?
-
oxidation in presence of benzaldehyde, no oxidation without benzaldehyde
-
-
?
spermine + O2 + H2O
?
-
rather poor substrate for hPAO, aldehyde supplementation greatly increased its degradation
-
-
?
spermine + O2 + H2O
?
-
-
-
?
spermine + O2 + H2O
?
poor substrate
-
-
?
spermine + O2 + H2O

spermidine + 3-aminopropanal + H2O2
least favoured substrate
-
-
?
spermine + O2 + H2O
spermidine + 3-aminopropanal + H2O2
-
-
-
?
additional information

?
-
Bjpao2 shows no activity with spermine
-
-
?
additional information
?
-
no activity with spermidine
-
-
?
additional information
?
-
-
no activity with spermidine
-
-
?
additional information
?
-
PAO expression is inducible by polyamine analogues and thus may contribute to the inhibition of cell growth
-
-
?
additional information
?
-
-
PAO expression is inducible by polyamine analogues and thus may contribute to the inhibition of cell growth
-
-
?
additional information
?
-
no efficient hydrolysis of: spermine, spermidine and N8-acetylspermidine, SL-11144, SL-11150, SL-11158 and SL-11156
-
-
?
additional information
?
-
-
no efficient hydrolysis of: spermine, spermidine and N8-acetylspermidine, SL-11144, SL-11150, SL-11158 and SL-11156
-
-
?
additional information
?
-
-
no production of spermidine from bis-alpha-methylspermine, hPAO
-
-
?
additional information
?
-
-
APAO is capable of metabolizing several N-alkylated polyamine derivatives, substrate specificity, overview. N1-(3-Ethylaminopropyl)butane-1,4-diamine trihydrochloride is a poor substrate
-
-
?
additional information
?
-
-
assay method development and validation, evaluation of quantitative determination of reaction products, overview
-
-
?
additional information
?
-
no substrate: N1-acetyl-3-methylspermidine
-
-
-
additional information
?
-
PAOX naturally metabolizes achiral N1-acetylated polyamines, displays aldehyde-controllable stereospecificity with chiral 1-methylated polyamines, like (R)- and (S)-1-methylspermidine
-
-
-
additional information
?
-
-
PAOX naturally metabolizes achiral N1-acetylated polyamines, displays aldehyde-controllable stereospecificity with chiral 1-methylated polyamines, like (R)- and (S)-1-methylspermidine
-
-
-
additional information
?
-
no activity with spermidine
-
-
?
additional information
?
-
-
no activity with spermidine
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,12-diaminododecane
1,12-diaminododecane derivatives could represent good candidates for the development of novel highly specific mPAO inhibitors
1,8-diaminooctane
competitive versus the polyamine
6,6'-[ethane-1,2-diyldi(piperidine-4,1-diyl)]bis[N-[(2-methoxyphenyl)methyl]hexan-1-amine]
17fold selectivity for spermine oxidase over polyamine oxidase
-
methoctramine
120fold selectivity for spermine oxidase over polyamine oxidase
-
N,N-di-2,3-butadienyl-1,4-butanediamine
-
i.e. MDL 72527, strong inhibition
N,N'-butanedienyl butanediamine
-
i.e. MDL 72527 or CPC-200, a small molecule specific inhibitor of polyamine oxidase, effectively blocks androgen-induced reactive oxygen species production in human prostate cancer cells, as well as significantly delays prostate cancer progression and death in animals developing spontaneous prostate cancer
N-(3-aminopropyl)-N-2-propenyl-1,4-butanediamine
-
moderate inhibition
N-(3-aminopropyl)-N-2,3-butadienyl-1,4-butanediamine
-
strong inhibition
N-[3-(2,3-butadienylamino)propyl]-1,4-butanediamine
-
strong inhibition
N-[3-(2-propenylamino) propyl]-1,4-butanediamine
-
moderate inhibition
N1,N1'-(pentane-1,5-diyl)bis[N6-[(2-methoxyphenyl)methyl]hexane-1,6-diamine]
9fold selectivity for spermine oxidase over polyamine oxidase
-
N1,N4-bis(2,3-butadienyl)-1,4-butanediamine
N1,N7-bis(6-[[(2-methoxyphenyl)methyl]amino]hexyl)heptane-1,7-diamine
40fold selectivity for spermine oxidase over polyamine oxidase
-
N1-acetyl-1,12-diaminododecane
competitive versus the polyamine
N1-acetyl-1,8-diaminooctane
competitive versus the polyamine
N1-acetyl-N3-pentyl-1,3-diaminopropane
competitive versus the polyamine
SL-11144
0.01 mM, 80% inhibition
SL-11150
0.01 mM, complete inhibition
SL-11158
0.01 mM, complete inhibition
MDL72527

-
-
MDL72527
irreversible. In addition to the covalent adduct, a second MDL72527 molecule is bound in the active site. Binding of MDL72527 is accompanied by altered conformations in the APAO backbone
N1,N4-bis(2,3-butadienyl)-1,4-butanediamine

2.5 mM, 70% inhibition of N1-acetylspermine oxidation
N1,N4-bis(2,3-butadienyl)-1,4-butanediamine
i.e. MDL 72,527
additional information

-
no inhibitory activity: N-(3-aminopropyl)-N-2-propynyl-1,4-butanediamine and N-[3-(2-propynylamino)propyl]-1,4-butanediamine
-
additional information
no inhibition at pH 7.5: 1,8-diaminooctane. Comparative study on murine PAO (mPAO) and SMO (mSMO) inhibition. The different behaviour displayed by 1,12-diaminododecane towards mPAO and mSMO reveals the occurrence of basic differences in the ligand binding mode of the two enzymes, the first enzyme interacting mainly with substrate secondary amino groups and the second one with substrate primary amino groups. The data provide the basis for the development of novel and selective inhibitors able to discriminate between mammalian SMO and PAO activities
-
additional information
-
no inhibition at pH 7.5: 1,8-diaminooctane. Comparative study on murine PAO (mPAO) and SMO (mSMO) inhibition. The different behaviour displayed by 1,12-diaminododecane towards mPAO and mSMO reveals the occurrence of basic differences in the ligand binding mode of the two enzymes, the first enzyme interacting mainly with substrate secondary amino groups and the second one with substrate primary amino groups. The data provide the basis for the development of novel and selective inhibitors able to discriminate between mammalian SMO and PAO activities
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Threatened
Serum polyamine-oxidase activity in spontaneous abortion.
Adenocarcinoma
A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.
Adenocarcinoma
Effect of polyamine oxidase inhibition on the colonic malignant transformation process induced by 1,2-dimethylhydrazine.
Adenocarcinoma
The growth of MAT-LyLu rat prostatic adenocarcinoma can be prevented in vivo by polyamine deprivation.
Arthritis, Rheumatoid
Polyamine oxidase activity in rheumatoid arthritis synovial fluid.
Brain Edema
Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion.
Brain Injuries
Contribution of polyamine oxidase to brain injury after trauma.
Brain Injuries, Traumatic
Contribution of polyamine oxidase to brain injury after trauma.
Brain Injuries, Traumatic
Elevated N1-acetylspermidine levels in gerbil and rat brains after CNS injury.
Brain Ischemia
Elevated N1-acetylspermidine levels in gerbil and rat brains after CNS injury.
Brain Ischemia
Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal.
Brain Ischemia
[Changes and significance of PAO activities and polyamine levels at different time of reperfusion after transient focal cerebral ischemia in rats]
Breast Neoplasms
Estrogens and polyamines in breast cancer: their profiles and values in disease staging.
Breast Neoplasms
Inducible expression of maize polyamine oxidase in the nucleus of MCF-7 human breast cancer cells confers sensitivity to etoposide.
Breast Neoplasms
Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines.
Carcinoma
Cytotoxic effects of the polyamine oxidase inactivator MDL 72527 to two human colon carcinoma cell lines SW480 and SW620.
Carcinoma
Endogenous and exogenous polyamines in support of tumor growth.
Carcinoma
Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells.
Carcinoma
Inhibition of polyamine oxidase improves the antitumoral effect of ornithine decarboxylase inhibitors.
Carcinoma
Inhibition of polyamine oxidase prevented cyclin-dependent kinase inhibitor-induced apoptosis in HCT 116 colon carcinoma cells.
Carcinoma
Polyamine oxidase activity in a human colonic carcinoma cell line.
Carcinoma
The gastrointestinal tract as polyamine source for tumor growth.
Carcinoma
[Effect of serum polyamine oxidase on normal and tumor cells]
Carcinoma, Hepatocellular
Expression of spermidine/spermine N1-acetyltransferase in growing Yoshida AH-130 hepatoma cells.
Carcinoma, Hepatocellular
[Effect of serum polyamine oxidase on normal and tumor cells]
Carcinoma, Lewis Lung
Endogenous and exogenous polyamines in support of tumor growth.
Carcinoma, Lewis Lung
Inhibition of polyamine oxidase improves the antitumoral effect of ornithine decarboxylase inhibitors.
Carcinoma, Lewis Lung
The gastrointestinal tract as polyamine source for tumor growth.
Cataract
Polyamine Oxidase Is Involved in Spermidine Reduction of Transglutaminase Type 2-Catalyzed ?H-Crystallins Polymerization in Calcium-Induced Experimental Cataract.
Cervical Intraepithelial Neoplasia
Cervical intraepithelial neoplasia is associated with increased polyamine oxidase and diamine oxidase concentrations in cervical mucus.
Colonic Neoplasms
Inhibition of polyamine oxidase enhances the cytotoxicity of polyamine oxidase substrates. A model study with N(1)-(n-octanesulfonyl)spermine and human colon cancer cells.
Colorectal Neoplasms
Polyamine oxidase activity and polyamine levels in human colorectal cancer and in normal surrounding mucosa.
Diabetes Mellitus, Type 1
Does polyamine oxidase activity influence the oxidative metabolism of children who suffer of diabetes mellitus?
Dwarfism
Role of polyamines in plant vascular development.
Epilepsy
A barley polyamine oxidase isoform with distinct structural features and subcellular localization.
Glioblastoma
Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation.
Hyperbilirubinemia, Neonatal
Polyamine oxidase activity in peripheral blood of newborn infants with neonatal hyperbilirubinemia: is bilirubin an antioxidant?
Infarction, Middle Cerebral Artery
Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion.
Infections
Free polyamine and polyamine regulation during pre?penetration and penetration resistance events in oat against crown rust (Puccinia coronata f. sp. avenae)
Infections
Polyamines as a common source of hydrogen peroxide in host- and nonhost hypersensitive response during pathogen infection.
Intestinal Volvulus
The polyamine metabolism of filarial worms as chemotherapeutic target.
Kidney Failure, Chronic
Polyamines in renal failure.
Kidney Failure, Chronic
[Physiological functions of polyamines and regulation of polyamine content in cells]
Leukemia
Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
Leukemia
Separation of two isozymes of polyamine oxidase from murine L1210 leukemia cells.
Leukemia
The gastrointestinal tract as polyamine source for tumor growth.
Lung Neoplasms
Highly expressed N1-acetylpolyamine oxidase detoxifies polyamine analogue N1-cyclopropylmethyl-N11-ethylnorspermine in human lung cancer cell line A549.
Malaria
Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase.
Malaria
Polyamine oxidase in human retroplacental serum inhibits the growth of Plasmodium falciparum.
Melanoma
Polyamine oxidase activity and concentration of polyamines in tissues and serum of hamsters with transplantational pigmented melanoma IC-Sofia.
Melanoma, Experimental
Polyamine transporter recognization and antitumor effects of anthracenymethyl homospermidine.
Neoplasms
Alterations in polyamine catabolic enzymes in human breast cancer tissue.
Neoplasms
Cervical intraepithelial neoplasia is associated with increased polyamine oxidase and diamine oxidase concentrations in cervical mucus.
Neoplasms
Cytotoxicity of the polyamine oxidase inactivator MDL 72527 to cancer cells: comparison with a saturated structural analogue.
Neoplasms
Effect of polyamine analogues and inhibition of polyamine oxidase on spermidine/spermine N1-acetyltransferase activity and cell proliferation.
Neoplasms
Effect of polyamine deprivation on the survival of intracranial glioblastoma bearing rats.
Neoplasms
Effect of polyamine oxidase inhibition on the colonic malignant transformation process induced by 1,2-dimethylhydrazine.
Neoplasms
Inhibition of polyamine oxidase activity affects tumor development during the maize-Ustilago maydis interaction.
Neoplasms
Inhibition of polyamine oxidase enhances the cytotoxicity of polyamine oxidase substrates. A model study with N(1)-(n-octanesulfonyl)spermine and human colon cancer cells.
Neoplasms
Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation.
Neoplasms
Microarray analysis uncovers retinoid targets in human bronchial epithelial cells.
Neoplasms
Polyamine catabolism in rodent and human cells in culture.
Neoplasms
Polyamine deprivation, malnutrition and tumor growth.
Neoplasms
Polyamine metabolism in maize tumors induced by Ustilago maydis.
Neoplasms
Polyamine oxidase activity and growth in human cancer cells.
Neoplasms
Polyamine oxidase activity in serum of cancer patients and healthy subjects.
Neoplasms
Purvalanol A is a strong apoptotic inducer via activating polyamine catabolic pathway in MCF-7 estrogen receptor positive breast cancer cells.
Neoplasms
Stimulation of clonal tumor cell growth in vitro by inhibiting the serum polyamine oxidase activity.
Neoplasms
Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis.
Neoplasms
The role of macrophage activation in chronic inflammation.
Neoplasms
The role of polyamine catabolism in anti-tumour drug response.
Neoplasms
[Effect of serum polyamine oxidase on normal and tumor cells]
Neurodegenerative Diseases
Targeting Polyamine Oxidase to Prevent Excitotoxicity-Induced Retinal Neurodegeneration.
Ovarian Neoplasms
Polyamine catabolism in platinum drug action: Interactions between oxaliplatin and the polyamine analogue N1,N11-diethylnorspermine at the level of spermidine/spermine N1-acetyltransferase.
Pancreatitis
Gossypol activates pancreatic polyamine catabolism in normal rats and induces acute pancreatitis in transgenic rats over-expressing spermidine/spermine N1-acetyltransferase.
Pancreatitis
[Methylated analogues of spermine and spermidine as tools to investigate cellular functions of polyamines and the enzymes of their metabolism]
Parasitemia
Trypanosoma brucei: polyamine oxidase mediated trypanolytic activity in the serum of naturally resistant cattle.
Prostatic Neoplasms
A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.
Prostatic Neoplasms
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.
Stroke
Acrolein, IL-6 and CRP as markers of silent brain infarction.
Stroke
Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke.
Stroke
[Physiological functions of polyamines and regulation of polyamine content in cells]
Ureteral Obstruction
Polyamine oxidase and diamine oxidase activities in acute ureteral obstruction.
Uterine Cervical Neoplasms
Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer.
Uterine Cervical Neoplasms
Cervical intraepithelial neoplasia is associated with increased polyamine oxidase and diamine oxidase concentrations in cervical mucus.
Vascular System Injuries
Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.